> Universities should stipulate in their technology transfer agreements that they would not use patents to prevent generic competition in places where the list

> Universities should stipulate in their technology transfer agreements that they would not use patents to prevent generic competition in places where the list price of the drug was unattainable based on average income if a drug were to be profitably sold to someone else for 20% of the price i’m paying for it, then wouldn’t i feel taken advantage of (more than i already am) when i’m denied access to that better price? i’m not saying means tested benefits are (or aren’t) all bad: just that in most places we use them it’s to enable transactions that very directly could not be profitable. a person buying food with foodstamps isn’t themselves paying the producer a profitable sum: each stamp has a direct “cost” that gets socialized, so it’s reasonable to believe that somebody well-off shouldn’t be eligible for them. but when the transaction is profitable at both price X and price 5X, the case to be made for why everyone shouldn’t be permitted that price of X is just a lot harder to explain.